European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH)
dc.contributor.author | Rack, KA | |
dc.contributor.author | Van den Berg, E | |
dc.contributor.author | Haferlach, C | |
dc.contributor.author | Beverloo, HB | |
dc.contributor.author | Costa, D | |
dc.contributor.author | Espinet, B | |
dc.contributor.author | Foot, N | |
dc.contributor.author | Jeffries, S | |
dc.contributor.author | Martin, K | |
dc.contributor.author | O'Connor, S | |
dc.contributor.author | Schoumans, J | |
dc.contributor.author | Talley, P | |
dc.contributor.author | Telford, Nicholas | |
dc.contributor.author | Stioui, S | |
dc.contributor.author | Zemanova, Z | |
dc.contributor.author | Hastings, RJ | |
dc.date.accessioned | 2020-02-27T16:55:30Z | |
dc.date.available | 2020-02-27T16:55:30Z | |
dc.date.issued | 2020 | en |
dc.identifier.citation | Rack KA, van den Berg E, Haferlach C, Beverloo HB, Costa D, Espinet B, et al. European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH). Leukemia. 2020. | en |
dc.identifier.pmid | 32042082 | en |
dc.identifier.doi | 10.1038/s41375-020-0736-x | en |
dc.identifier.uri | http://hdl.handle.net/10541/622796 | |
dc.language.iso | en | en |
dc.relation.url | https://dx.doi.org/10.1038/s41375-020-0736-x | en |
dc.title | European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH) | en |
dc.type | Article | en |
dc.contributor.department | GenQA, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK | en |
dc.identifier.journal | Leukemia | en |
dc.description.note | en] | |
refterms.dateFOA | 2020-03-02T14:53:18Z |